Connect · Collaborate · Cure
Act for Hope is a collaborative initiative dedicated to accelerating the growth of the CGT industry and transforming patient lives worldwide
News articles
Displaying the latest articles
Business 101 for CGT Startups Working with CDMOs: How CDAs and MSAs Shape Your Future Tech Transfer
Prepared by the Knowledge Sharing Workstream Cell & gene therapy startups don’t just “outsource manufacturing.” In many cases, they outsource…
Unlocking Collaboration Through Data
In today’s fast-paced world of drug development, no company can afford to work in isolation. The pharmaceutical industry has entered…
Structured Sharing = Better Innovation
Collaboration and knowledge sharing are central drivers of innovation within India’s growing biotechnology sector. As multinational pharmaceutical companies form deeper…
From Insights to Impact
A recent study examines how knowledge sharing shapes employee innovative behavior within the pharmaceutical logistics industry, a sector where operational…
Sharing is Caring: The Secrets of CGT
In our latest blog, we explore a powerful conversation that is gaining momentum across the cell and gene therapy landscape:…
Unlocking Collective Intelligence
Every time we solve the same problem in isolation, we delay patient access. In this piece, Alexander Seyf,…
Act for Hope: Building a Shared Database for CAR-T Manufacturing
CGT manufacturing progress is often slowed by fragmented data environments, inconsistent documentation practices, and limited mechanisms for standardized data sharing…
Closing the Manufacturing Knowledge Gap Through Data Sharing
Manufacturers in the CGT space often work through similar scientific and operational challenges independently, which leads to duplicated effort, slower…
The Role of Digital Infrastructure in Scaling CGT Manufacturing
As an increasing number of cell and gene therapies advance toward commercial scale, the industry is coming to understand that…
Bridging Accreditation and Access: FACT x Act for Hope
As cell and gene therapies transition from niche innovations to mainstream treatment options, the challenge is no longer just scientific,…
Access Starts with Alignment
Access to advanced therapies isn’t just a clinical challenge it’s a systemic one. As cell and gene therapies move from…
Collaboration is Key
When payers and accreditation bodies align early, everyone benefits, especially patients. Our work with accreditation frameworks aims to build those…
Rethinking Accreditation for Access
Accreditation is essential for ensuring patient safety and maintaining high standards of care, but it shouldn’t become a barrier to…
From Visibility to Impact
Empowering patients, advocates, and organisations with a shared view of the cell and gene therapy (CGT) ecosystem isn’t just a…
Mapping Initiatives, Empowering Patients
There’s incredible work happening across the CGT ecosystem, but too often, it’s happening in isolation. A connected portal can turn…
Mapping the Pathway to Real Patient Access
In the cell and gene therapy space, the promise of innovation means little if patients can’t access treatments when they…
Breaking Down Silos to Build Access
Access to cell and gene therapies shouldn’t depend on where a patient lives or how well initiatives are connected. When…
Member Spotlight: Brad Watts, Advocate & Vice President, Business Development Executive at Conner Strong & Buckelew
“If it wasn’t for this treatment, I very likely would not be here today. Instead, it has given me a…
Member Spotlight: Brian Fry, Senior Director of Business Development, Cellipont Bioservices
“Progress in this field shouldn’t happen in silos. By sharing what we learn and supporting one another across the community,…
Member Spotlight: Paula Lam Ph.D., CSO, BioCell Innovations | Adjunct Associate Professor, Duke-NUS & NUS
“The complexity of manufacturing remains a key barrier to translating these innovations into widely accessible treatments.” With over two decades…
Member Spotlight: Diana Hernandez, Director of Immune and Advanced Therapies at Anthony Nolan
“The only thing worse than not having a potential treatment is having one you can’t access.” In our latest Member…
Member Spotlight: Samuel Molina, Cell-based BioConsultant
“The best way to deliver value to the patient is by working closer to them, and, ultimately with them.” In…
Member Spotlight: Patrick Hanley, Chief & Director, Cellular Therapy Program at Children’s National
“If we change the paradigm of how CGTs are developed and commercialized, I think we’ll see the dam break and…
Member Spotlight: Leo Wang MD, PhD
“Breakthrough therapies only matter if patients can truly access them” In our latest Member Spotlight, we feature Leo Wang, paediatric…
Member Spotlight: Alexander Seyf, Co-Founder
“Technology is only as powerful as the mission it serves: Patient access” We’re launching our Member Spotlight Series with Alexander…
ISCT Cell Therapy Leadership Training Program 2025
Act for Hope Involved in the Launch of the ISCT Cell Therapy Leadership Training Program 2025 The ISCT…
Monthly Update: October
Hope in Action: Monthly Update Each month, we share highlights from across our workstreams and how they’re helping…
The Story Behind Act for Hope
Why did we start Act for Hope? In this short fireside conversation, our founder Alexander Seyf reflects on the origins…
Unlocking Collective Intelligence
Every time we solve the same problem in isolation, we delay patient access. In this piece, Alexander Seyf,…
Ring That Bell
“Ring That Bell” – A Story of Resilience, Advocacy, and Innovation “Ring That Bell” brings together Irish musician Mags McCarthy…
Collaborative Portal
Our Portal is designed as a central hub for a structured approach to collaboration and knowledge sharing. It brings together a diverse community – from students and early-career professionals to seasoned experts to connect , share insights and accelerate the development and delivery of these life changing therapies.
Coming SoonIndustry Initiatives
The Industry Initiatives Portal connects and maps CGT efforts across the ecosystem, enhancing visibility, collaboration, and alignment. It reduces duplication, shares resources, and accelerates collective progress.
Coming Soon
Help Us Spread Hope
Every contribution helps Act for Hope unite industry leaders. Together, we break down silos and leverage shared knowledge to make cell and gene therapy more widely understood and accessible to patients worldwide. Scan the code to make a difference.
Donate TodayActivities and Events
The annual Act for Hope Summit unites voices across the CGT community to reflect, share knowledge, and shape future priorities. Through open dialogue and collaborative sessions, it drives alignment, innovation, and impact for patients.
